###begin article-title 0
Lead and delta-Aminolevulinic Acid Dehydratase Polymorphism: Where Does It Lead? A Meta-Analysis
###end article-title 0
###begin p 1
The authors declare they have no competing financial interests.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 160 165 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 170 175 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
Lead poisoning affects many organs in the body. Lead inhibits delta-aminolevulinic acid dehydratase (ALAD), an enzyme with two co-dominantly expressed alleles, ALAD1 and ALAD2.
###end p 3
###begin title 4
Objective
###end title 4
###begin p 5
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
Our meta-analysis studied the effects of the ALAD polymorphism on a) blood and bone lead levels and b) indicators of target organ toxicity.
###end p 5
###begin title 6
Data source
###end title 6
###begin p 7
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
###xml 101 112 101 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2/2-2</italic>
We included studies reporting one or more of the following by individuals with genotypes ALAD1-1 and ALAD1-2/2-2: blood lead level (BLL), tibia or trabecular lead level, zinc protoporphyrin (ZPP), hemoglobin, serum creatinine, blood urea nitrogen (BUN), dimercaptosuccinic acid-chelatable lead, or blood pressure.
###end p 7
###begin title 8
Data extraction
###end title 8
###begin p 9
Sample sizes, means, and standard deviations were extracted for the genotype groups.
###end p 9
###begin title 10
Data synthesis
###end title 10
###begin p 11
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 186 190 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 266 271 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
There was a statistically significant association between ALAD2 carriers and higher BLL in lead-exposed workers (weighted mean differences of 1.93 mug/dL). There was no association with ALAD carrier status among environmentally exposed adults with BLLs < 10 mug/dL. ALAD2 carriers were potentially protected against adverse hemapoietic effects (ZPP and hemoglobin levels), perhaps because of decreased lead bioavailability to heme pathway enzymes.
###end p 11
###begin title 12
Conclusion
###end title 12
###begin p 13
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
Carriers of the ALAD2 allele had higher BLLs than those who were ALAD1 homozygous and higher hemoglobin and lower ZPP, and the latter seems to be inversely related to BLL. Effects on other organs were not well delineated, partly because of the small number of subjects studied and potential modifications caused by other proteins in target tissues or by other polymorphic genes.
###end p 13
###begin p 14
###xml 409 470 409 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-ehp0115-000035">Agency for Toxic Substances and Disease Registry (ATSDR) 1999</xref>
###xml 153 161 <span type="species:ncbi:9606">children</span>
Lead poisoning is a complex disorder affecting many organs in the body, including developing red blood cells, the kidneys, and the nervous system. Young children are most susceptible to the toxic effects of lead. Major concerns are the cognitive and neurobehavioral deficits resulting from lead exposure levels that were previously considered safe. High levels of exposure can cause encephalopathy and death [Agency for Toxic Substances and Disease Registry (ATSDR) 1999].
###end p 14
###begin p 15
###xml 90 112 90 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38-ehp0115-000035">Rabinowitz et al. 1976</xref>
###xml 770 792 770 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38-ehp0115-000035">Rabinowitz et al. 1976</xref>
###xml 1012 1024 1012 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-ehp0115-000035">Marcus 1985a</xref>
###xml 1026 1031 1026 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-ehp0115-000035">1985b</xref>
###xml 401 408 <span type="species:ncbi:9606">persons</span>
Lead deposition in the body consists of three major pools: blood, bone, and soft tissues (Rabinowitz et al. 1976). The blood pool accounts for only 2% of the total body burden, unless there is an acute exposure, but is a rapidly exchangeable component. The bone pool contains > 95% of the total body burden, where it may be mobilized and contribute to the blood lead level (BLL) in previously exposed persons. Differences in lead accumulation in various bone types have been reported. Tibia concentrations differ from those observed in the patella. The cortical bone of the tibia represents a long-term storage depot with an elimination half-life for lead in excess of a decade. In contrast, the more dynamic trabecular bone of the patella exhibits a shorter half-life (Rabinowitz et al. 1976).The remainder of the total body load is distributed in an intermediate pool of soft tissues, skin, and muscle. Elimination half-lives for lead are estimated at 30-40 days in blood and up to 20 years or longer in bone (Marcus 1985a, 1985b). Lead is eliminated mainly in the urine.
###end p 15
###begin p 16
###xml 226 250 222 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0115-000035">Onalaja and Claudio 2000</xref>
###xml 252 270 248 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56-ehp0115-000035">Warren et al. 1998</xref>
###xml 405 424 401 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-ehp0115-000035">Chisolm et al. 1985</xref>
###xml 674 692 670 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56-ehp0115-000035">Warren et al. 1998</xref>
Lead is a potent inhibitor of delta-aminolevulinic acid dehydratase (ALAD), copropor-phyrinogen oxidase, and ferrochelatase, enzymes that catalyze the second, sixth, and final steps, respectively, in the biosynthesis of heme (Onalaja and Claudio 2000; Warren et al. 1998). Because the metal has the greatest effect on ALAD, measurement of ALAD activity can be used as a marker of effect of lead exposure (Chisolm et al. 1985). ALAD, an octameric zinc-containing enzyme, catalyzes the condensation of two molecules of 5-aminolevulinic acid (ALA) into one molecule of monopyrrole porphobilinogen (PBG). Inhibition of ALAD activity produces increased urinary excretion of ALA (Warren et al. 1998).
###end p 16
###begin p 17
###xml 333 358 329 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-ehp0115-000035">Brennan and Cantrill 1979</xref>
Lead displaces zinc from the enzyme's active site, and the inactivation of ALAD has been implicated in the pathogenesis of lead poisoning. The resulting accumulation of its substrate, ALA, has been shown to have a neuropathogenic effect, probably by acting as a gamma-aminobutyric acid (GABA) receptor agonist in the nervous system (Brennan and Cantrill 1979).
###end p 17
###begin p 18
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 238 261 238 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp0115-000035">Battistuzzi et al. 1981</xref>
###xml 369 374 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 408 413 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 518 537 516 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59-ehp0115-000035">Wetmur et al. 1991b</xref>
###xml 633 638 631 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 643 648 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 709 714 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 719 724 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 844 849 842 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 858 876 856 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-ehp0115-000035">Kelada et al. 2001</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ALAD, encoded by a single gene localized to the chromosome 9q34 region, is a polymorphic enzyme with two alleles, ALAD1 and ALAD2 [Single Nucleotide Polymorphism database (dbSNP) ID: rs1800435; ], which are co-dominantly expressed (Battistuzzi et al. 1981). The difference between the two alleles lies in a single G-->C transversion mutation of nucleotide 177 in ALAD2; the allozyme resulting from the ALAD2 allele contains the substitution of a neutral asparagine for a positively charged lysine at residue 59 (Wetmur et al. 1991b). Three differently charge allozymes, ALAD1-1, 1-2, and 2-2, result from the expression of the ALAD1 and ALAD2 genes. In several white populations, the frequencies of the ALAD1 and ALAD2 genes have been estimated to be 0.9 and 0.1, respectively. Asian and African populations have lower frequencies of the ALAD2 allele (Kelada et al. 2001).
###end p 18
###begin p 19
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 314 337 314 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp0115-000035">Battistuzzi et al. 1981</xref>
###xml 452 471 452 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59-ehp0115-000035">Wetmur et al. 1991b</xref>
###xml 605 609 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 720 739 720 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62-ehp0115-000035">Ziemsen et al. 1986</xref>
###xml 849 867 849 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0115-000035">Astrin et al. 1987</xref>
###xml 942 947 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 1019 1024 1019 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 1075 1080 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 1149 1168 1149 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58-ehp0115-000035">Wetmur et al. 1991a</xref>
###xml 1261 1266 1261 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 1304 1309 1304 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 1534 1539 1534 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 793 801 <span type="species:ncbi:9606">children</span>
Several epidemiologic studies have attempted to correlate the ALAD allelic variations with a differential susceptibility to lead poisoning. The biologic plausibility for a differential role of the two alleles lies in the fact that the lysine substitution at residue 59 changes the electrical charge of the enzyme (Battistuzzi et al. 1981); the more electronegative ALAD2 enzyme may thus have a higher affinity/stability for the lead cation than ALAD1 (Wetmur et al. 1991b). This could result in an alteration of lead toxicokinetics and susceptibility to lead toxicity. The first studies comparing BLL and ALAD polymorphism were conducted on a chronically exposed population of 202 male lead workers in a German factory (Ziemsen et al. 1986), and an environmentally exposed population of 1,051 children with elevated free erythrocyte protoporphyrin (Astrin et al. 1987). These studies showed that individuals carrying one or two copies of the ALAD2 allele exhibited higher BLLs than homozygous individuals with only the ALAD1 allele. These findings led to the suggestion that ALAD2 may be a determinant for increased susceptibility to lead toxicity (Wetmur et al. 1991a). However, some studies have reported either no difference among individuals homozygous for ALAD1 relative to individuals carrying the ALAD2 allele, or the differences among the two groups were not statistically significant. The extreme variability in the published data is due to several factors: relatively small numbers of subjects, different frequencies of the ALAD2 allele in various populations, and different levels of lead exposure as determined by BLLs in the populations studied. We used a series of meta-analyses to quantify the effects of this genetic polymorphism and to understand lead toxicokinetics.
###end p 19
###begin title 20
Methods
###end title 20
###begin title 21
Study selection
###end title 21
###begin p 22
MEDLINE (National Library of Medicine 2006) and Web of Science (Thomson Scientific 2006) databases were searched to January 2006 for English-language publications of observational studies. The citations in the articles identified were also searched to find other potentially eligible studies. Common text words and Medical Subject Headings (MeSH) related to lead poisoning, gene polymorphism, and ALAD were used. No attempt was made to contact the authors of any of the articles, except to resolve discrepancies in the reported values.
###end p 22
###begin p 23
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a priori</italic>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
###xml 178 189 178 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2/2-2</italic>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
We required that two a priori criteria be met for inclusion in the meta-analysis: a) sample sizes, means, and SDs were either reported or could be determined for the ALAD1-1 and ALAD1-2/2-2 genotypes; and b) combined with one or more of the following measures-BLL, tibia lead level, trabecular (patella or calcaneus) lead level, zinc protoporphyrin (ZPP), hemoglobin, serum creatinine, dimercaptosuccinic acid-chelatable lead, and systolic or diastolic blood pressure. When multiple studies used the same cohort of subjects, the first publication that reported the values of the variables of interest was included.
###end p 23
###begin title 24
Data extraction
###end title 24
###begin p 25
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2-2</italic>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2</italic>
###xml 169 185 169 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60-ehp0115-000035">Wu et al. (2004)</xref>
Sample sizes, means, and SDs according to genotype (homozygous ALAD1-1 and ALAD2-2 and heterozygous ALAD1-2) were extracted independently by two authors (F.S and D.M.). Wu et al. (2004) reported data in groups of workers subjected to high and low lead exposures. We mathematically combined the data of the two groups to extract the means for all exposed workers according to the genotype. The pooled estimate of the variance from two independent samples was used to extract the SDs according to genotype. Therefore, only one effect size was entered in the model. The data from each study were entered twice to minimize data-entry errors.
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
###xml 189 200 189 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2/2-2</italic>
###xml 209 216 209 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
###xml 942 943 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 943 944 943 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1030 1032 1030 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 1045 1046 1045 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 1046 1047 1046 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1142 1143 1142 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 1143 1144 1143 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1172 1173 1172 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 1173 1174 1173 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1209 1210 1209 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 1210 1211 1210 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1243 1244 1243 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 1244 1245 1244 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1281 1300 1281 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp0115-000035">Higgins et al. 2003</xref>
###xml 1364 1372 1364 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a priori</italic>
###xml 1608 1631 1608 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp0115-000035">Begg and Mazumdar(1994)</xref>
###xml 1639 1658 1639 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-ehp0115-000035">Egger et al. (1997)</xref>
###xml 1664 1666 1664 1666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 1477 1485 <span type="species:ncbi:9606">children</span>
The data were analyzed using Stata software version 7 (StataCorp., College Station, TX, USA). In each study the size of the effect was calculated by the difference between the means of the ALAD1-2/2-2 and the ALAD1-1 groups. Each mean difference was weighted according to the inverse of its variance, and the average was taken [weighted mean difference (WMD)]. To combine data from studies in which the same outcome was measured by different scales (serum creatinine), or when the outcome value was measured by different methods (bone lead, ZPP), the mean difference was standardized by dividing by the within-group SD; the results were then weighted and the average, or standardized mean difference (SMD), taken. The WMD or SMD in each study was pooled using a random-effects model. Results are given with 95% confidence intervals (CIs). Between-study heterogeneity in the results of the studies was assessed using a chi-square test and the I2 measure of inconsistency. Significant heterogeneity was defined as a chi-square test p-value < 0.1. I2 takes values between 0% and 100% with higher values denoting greater degree of heterogeneity (I2 = 0-25%: no heterogeneity; I2 = 25-50%: moderate heterogeneity; I2 = 50-75%: large heterogeneity; I2 = 75-100%: extreme heterogeneity) (Higgins et al. 2003). Furthermore, to examine between-study heterogeneity, we used a priori stratified analyses including the study design (occupational and environmental studies) and age status (children and adults) and presence of Hardy-Weinberg equilibrium (HWE). Publication bias was assessed using the methods proposed by Begg and Mazumdar(1994) and by Egger et al. (1997). All p-values are two-tailed.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 91 99 91 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0115-000035">Figure 1</xref>
###xml 236 241 236 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 427 443 427 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46-ehp0115-000035">Shen et al. 2001</xref>
###xml 676 697 676 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0115-000035">Alexander et al. 1998</xref>
###xml 699 717 699 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0115-000035">Astrin et al. 1987</xref>
###xml 719 739 719 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-ehp0115-000035">Duydu and Suzen 2003</xref>
###xml 741 760 741 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0115-000035">Fleming et al. 1998</xref>
###xml 762 779 762 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp0115-000035">Hsieh et al. 2000</xref>
###xml 781 795 781 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0115-000035">Hu et al. 2001</xref>
###xml 797 812 797 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0115-000035">Kim et al. 2004</xref>
###xml 814 832 814 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0115-000035">Lee BK et al. 2001</xref>
###xml 834 852 834 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp0115-000035">Lee SS et al. 2001</xref>
###xml 854 877 854 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp0115-000035">Perez-Bravo et al. 2004</xref>
###xml 879 896 879 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp0115-000035">Sakai et al. 2000</xref>
###xml 898 918 898 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp0115-000035">Schwartz et al. 1995</xref>
###xml 920 925 920 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp0115-000035">1997a</xref>
###xml 927 932 927 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44-ehp0115-000035">1997b</xref>
###xml 934 938 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0115-000035">2000</xref>
###xml 940 964 940 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47-ehp0115-000035">Sithisarankul et al.1997</xref>
###xml 966 983 966 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 985 1002 985 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50-ehp0115-000035">Suzen et al. 2003</xref>
###xml 1004 1025 1004 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51-ehp0115-000035">Theppeang et al. 2004</xref>
###xml 1027 1045 1027 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57-ehp0115-000035">Weaver et al. 2003</xref>
###xml 1047 1066 1047 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58-ehp0115-000035">Wetmur et al. 1991a</xref>
###xml 1068 1082 1068 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-000035">Wu et al. 2003</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60-ehp0115-000035">2004</xref>
###xml 1090 1109 1090 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62-ehp0115-000035">Ziemsen et al. 1986</xref>
###xml 1323 1330 1323 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-ehp0115-000035">Table 1</xref>
###xml 417 425 <span type="species:ncbi:9606">children</span>
The search procedure yielded 45 references that were retrieved for additional information (Figure 1). We initially excluded 4 review papers, 5 non-English research articles, and 2 articles that reported data on different variant of the ALAD2 polymorphism. Of the remaining 34 articles, 7 did not have relevant data for effect size calculation. Moreover, the corresponding author of a study of environmentally exposed children (Shen et al. 2001) was contacted twice by monthly e-mail to resolve some discrepancy in their reported study. Three months after failing to receive an answer, we decided to exclude the study. Therefore, 24 studies were included in the meta-analysis (Alexander et al. 1998; Astrin et al. 1987; Duydu and Suzen 2003; Fleming et al. 1998; Hsieh et al. 2000; Hu et al. 2001; Kim et al. 2004; Lee BK et al. 2001; Lee SS et al. 2001; Perez-Bravo et al. 2004; Sakai et al. 2000; Schwartz et al. 1995, 1997a, 1997b, 2000; Sithisarankul et al.1997; Smith et al. 1995; Suzen et al. 2003; Theppeang et al. 2004; Weaver et al. 2003; Wetmur et al. 1991a; Wu et al. 2003, 2004; Ziemsen et al. 1986), and of these, 11 were multiple publications that often had other different outcomes of interest. When we found a discrepancy in the reported studies, the authors were contacted and the corrected data were used. Table 1 characterizes the studies that did meet criteria for inclusion.
###end p 29
###begin title 30
###xml 5 39 5 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphism and blood lead level.</italic>
ALAD polymorphism and blood lead level.
###end title 30
###begin p 31
###xml 27 48 27 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0115-000035">Alexander et al. 1998</xref>
###xml 50 69 50 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0115-000035">Fleming et al. 1998</xref>
###xml 71 86 71 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0115-000035">Kim et al. 2004</xref>
###xml 88 105 88 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp0115-000035">Sakai et al. 2000</xref>
###xml 107 127 107 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp0115-000035">Schwartz et al. 1995</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0115-000035">2000</xref>
###xml 135 152 135 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50-ehp0115-000035">Suzen et al. 2003</xref>
###xml 154 173 154 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58-ehp0115-000035">Wetmur et al. 1991a</xref>
###xml 175 189 175 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60-ehp0115-000035">Wu et al. 2004</xref>
###xml 299 316 299 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 318 335 318 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp0115-000035">Hsieh et al. 2000</xref>
###xml 337 351 337 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-000035">Wu et al. 2003</xref>
###xml 375 398 375 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp0115-000035">Perez-Bravo et al. 2004</xref>
###xml 400 419 400 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58-ehp0115-000035">Wetmur et al. 1991a</xref>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 602 623 602 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58-ehp0115-000035">Wetmur et al. (1991a)</xref>
###xml 720 739 720 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62-ehp0115-000035">Ziemsen et al. 1986</xref>
###xml 781 799 781 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0115-000035">Astrin et al. 1987</xref>
###xml 951 970 951 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62-ehp0115-000035">Ziemsen et al. 1986</xref>
###xml 1051 1069 1051 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0115-000035">Astrin et al. 1987</xref>
###xml 1072 1079 1072 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-ehp0115-000035">Table 2</xref>
###xml 1107 1111 1107 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 365 373 <span type="species:ncbi:9606">children</span>
###xml 771 779 <span type="species:ncbi:9606">children</span>
###xml 994 1002 <span type="species:ncbi:9606">children</span>
Nine occupational studies (Alexander et al. 1998; Fleming et al. 1998; Kim et al. 2004; Sakai et al. 2000; Schwartz et al. 1995, 2000; Suzen et al. 2003; Wetmur et al. 1991a; Wu et al. 2004) were included in our analysis, and 5 environmental exposure studies of which 3 were conducted among adults (Smith et al. 1995; Hsieh et al. 2000; Wu et al. 2003) and 2 among children (Perez-Bravo et al. 2004; Wetmur et al. 1991a). Thus, a total of 14 studies were included in our analysis of blood lead level and ALAD polymorphism. Each of the studies was rechecked for HWE. We did not find HWE in the study by Wetmur et al. (1991a) that presented separate data on previously reported studies of occupational exposure in adults (Ziemsen et al. 1986) and environmental exposure in children (Astrin et al. 1987). The absence of HWE is most likely because of ethnicities of the populations: the occupational study comprised workers of German and Turkish origins (Ziemsen et al. 1986), whereas the study of children included whites, blacks, Hispanics, and Asians (Astrin et al. 1987). Table 2 shows the frequency of the ALAD polymorphism and the status of the HWE in the studies analyzed.
###end p 31
###begin p 32
###xml 159 181 159 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53-ehp0115-000035">Trikalinos et al. 2006</xref>
There is evidence that inclusion of studies that deviate from HWE can affect the pooled estimate and be potential sources of heterogeneity across the studies (Trikalinos et al. 2006). Hence, we conducted pooled analysis with and without studies that deviated from HWE.
###end p 32
###begin p 33
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 219 220 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 220 222 218 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 232 233 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 243 244 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 244 245 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 256 263 254 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp0115-000035">Table 3</xref>
###xml 265 273 263 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2-ehp0115-000035">Figure 2</xref>
###xml 492 493 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 493 494 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 558 559 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 559 560 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 647 648 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 648 649 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 741 742 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 742 744 738 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 754 755 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 834 835 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 835 836 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 847 854 843 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp0115-000035">Table 3</xref>
###xml 921 926 917 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 1043 1048 1038 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 1318 1319 1312 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1373 1374 1367 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 424 432 <span type="species:ncbi:9606">children</span>
###xml 548 556 <span type="species:ncbi:9606">children</span>
Pooled WMD analysis among the 14 studies, which included a total of 6,672 subjects, 5,861 (87.84%) were homozygous for ALAD1 and 811 (12.16%) carried the ALAD2 allele, showed a large heterogeneity among the studies (chi213 = 54.75; p = 0.000; I2 = 76.3%) (Table 3; Figure 2). In subgroup analysis (subgroups were defined by the type of study and by population, that is, occupationally and environmentally exposed adults and children), there was no heterogeneity between occupational studies (I2 = 0), between the studies of environmentally exposed children (I2 = 0), and moderate heterogeneity among the studies of environmentally exposed adults (I2 = 55.2%). After removal of the studies not in HWE, the overall heterogeneity decreased (chi211 = 17.92; p = 0.07), and the variation in WMD attributable to heterogeneity was moderate (I2 = 38.6%) (Table 3). Overall, the pooled WMD analysis indicated that the carriers of ALAD2 allele had a significantly higher BLL (2.31 mug/dL; 95% CI, 0.93 to 3.70) compared with carriers homozygous for the ALAD1 allele, a finding that was mostly driven by the occupational studies. Removal of the two studies not in HWE resulted in a not significantly higher WMD level of BLL (0.86 mug/dL; 95% CI, -0.1 to 1.73). There was no evidence of publication bias according to Begg's test (p = 1.0, with continuity correction) and Egger's test (p = 0.10).
###end p 33
###begin title 34
Occupational studies
###end title 34
###begin p 35
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 151 152 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 163 171 162 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0115-000035">Figure 3</xref>
###xml 206 213 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp0115-000035">Table 3</xref>
Lead workers carrying the ALAD2 allele had higher BLLs (WMD = 2.56 mug/dL; 95% CI, 1.21 to 3.90), with the difference being statistically significant (p = 0.027) (Figure 3). Analysis of the studied in HWE (Table 3) resulted in a decreased but still significant higher WMD (2.24 mug/dL; 95% CI, 0.85 to 3.62).
###end p 35
###begin title 36
Environmental adult studies
###end title 36
###begin p 37
By contrast, the WMD in adults environmentally exposed to lead was 0.05 mug/dL (95% CI, -0.79 to 0.88), which was not statistically significant.
###end p 37
###begin title 38
###xml 14 22 <span type="species:ncbi:9606">children</span>
Environmental children studies
###end title 38
###begin p 39
###xml 136 141 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 176 177 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 323 344 322 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58-ehp0115-000035">Wetmur et al. (1991a)</xref>
###xml 38 46 <span type="species:ncbi:9606">children</span>
Pooled analysis of the two studies of children showed a WMD in BLL of 7.34 mug/dL (95% CI, 4.92 to 9.76), with the individuals carrying ALAD2 having significantly higher BLLs (p = 0.00). However, the data should be viewed cautiously because other than deviation from HWE, the individuals selected for the study reported by Wetmur et al. (1991a) had higher initial clinical evaluations of elevated erythrocyte protoporphyrin (FEP) levels thus introducing potentially serious selection bias in the study design.
###end p 39
###begin title 40
###xml 5 36 5 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphism and heme synthesis</italic>
ALAD polymorphism and heme synthesis
###end title 40
###begin title 41
Zinc protoporphyrin (ZPP)
###end title 41
###begin p 42
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 69 90 69 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0115-000035">Alexander et al. 1998</xref>
###xml 92 107 92 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0115-000035">Kim et al. 2004</xref>
###xml 109 127 109 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp0115-000035">Lee SS et al. 2001</xref>
###xml 129 146 129 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp0115-000035">Sakai et al. 2000</xref>
###xml 148 168 148 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp0115-000035">Schwartz et al. 1995</xref>
###xml 170 184 170 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60-ehp0115-000035">Wu et al. 2004</xref>
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD 2</italic>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0115-000035">Figure 3</xref>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 514 515 512 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 515 516 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 525 526 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 536 537 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 537 538 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 662 663 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 716 717 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Six published occupational studies related ZPP to ALAD polymorphism (Alexander et al. 1998; Kim et al. 2004; Lee SS et al. 2001; Sakai et al. 2000; Schwartz et al. 1995; Wu et al. 2004). Because the methods used to measure ZPP were not uniform, we calculated the SMD. The overall pooled SMD was -0.09, indicating that individuals carrying the ALAD 2 allele had lower ZPP values (Figure 3). However, the SMD was not statistically significant (95% CI, -0.22 to 0.03; p = 0.13). Heterogeneity was not significant (chi25 = 3.88, p = 0 .56; I2 = 0.0%), indicating that the studies were homogeneous. There was no evidence of publication bias according to Begg's test (p =1.0, with continuity correction) and Egger's test (p = 0.37).
###end p 42
###begin title 43
Hemoglobin
###end title 43
###begin p 44
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 105 120 105 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0115-000035">Kim et al. 2004</xref>
###xml 122 143 122 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp0115-000035">Schwartz et al. 1997a</xref>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0115-000035">2000</xref>
###xml 151 165 151 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60-ehp0115-000035">Wu et al. 2004</xref>
###xml 207 224 207 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp0115-000035">Hsieh et al. 2000</xref>
###xml 272 295 272 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp0115-000035">Perez-Bravo et al. 2004</xref>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 420 428 420 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4-ehp0115-000035">Figure 4</xref>
###xml 648 649 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 698 699 696 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 699 700 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 709 710 707 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 718 719 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 719 720 717 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 887 888 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 943 944 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 262 270 <span type="species:ncbi:9606">children</span>
Six published cross-sectional studies related hemoglobin levels to ALAD polymorphism: four occupational (Kim et al. 2004; Schwartz et al. 1997a, 2000; Wu et al. 2004), one on environmentally exposed adults (Hsieh et al. 2000), and one on environmentally exposed children (Perez-Bravo et al. 2004) studies. Individuals carrying ALAD2 had higher hemoglobin measurements (WMD = 0.18 g/dL; 95% CI, 0.05 to 0.31; p = 0.007) (Figure 4). However, stratification by study design shows that individuals environmentally exposed to lead carrying ALAD2 had a not statistically significant higher hemoglobin measurement (WMD = 0.22 g/dL; 95% CI, -0.20 to 0.63; p = 0.306). Heterogeneity was not significant (chi25 = 1.55; p = 0.9; I2 = 0.0%); the studies are thus homogeneous and it is appropriate to use the summary weighted mean. There was no evidence of publication bias according to Begg's test (p = 0.45, with continuity correction) and Egger's test (p = 0.66).
###end p 44
###begin title 45
###xml 5 38 5 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphism and bone compartment</italic>
ALAD polymorphism and bone compartment
###end title 45
###begin title 46
Tibia lead level
###end title 46
###begin p 47
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 148 166 148 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0115-000035">Lee BK et al. 2001</xref>
###xml 168 186 168 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp0115-000035">Lee SS et al. 2001</xref>
###xml 188 206 188 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57-ehp0115-000035">Weaver et al. 2003</xref>
###xml 208 222 208 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-000035">Wu et al. 2003</xref>
###xml 282 303 282 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp0115-000035">Bellinger et al. 1994</xref>
###xml 305 323 305 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57-ehp0115-000035">Weaver et al. 2003</xref>
###xml 411 430 411 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0115-000035">Fleming et al. 1998</xref>
###xml 432 452 432 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0115-000035">Schwartz et al. 2000</xref>
###xml 497 514 497 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 516 530 516 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-000035">Wu et al. 2003</xref>
###xml 787 788 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 799 806 799 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-000035">Table 4</xref>
Ten studies reported data on lead levels in tibia bone and ALAD polymorphism as an outcome measure. Four studies that relied on previous data sets (Lee BK et al. 2001; Lee SS et al. 2001; Weaver et al. 2003; Wu et al. 2003) and two that did not have data based on the polymorphism (Bellinger et al. 1994; Weaver et al. 2003) were excluded, leaving four studies for analysis: two studies involving lead workers (Fleming et al. 1998; Schwartz et al. 2000) and two of environmentally exposed adults (Smith et al. 1995; Wu et al. 2003). Because the methods used to measure tibia lead levels were not the same in all studies, the pooled SMD was calculated. The overall pooled SMD of -0.07 was not significant (95% CI, 0.20 to 0.05) and no significant heterogeneity existed among the studies (I2 = 0.0%) (Table 4).
###end p 47
###begin title 48
Trabecular (patella and calcaneus) lead level
###end title 48
###begin p 49
###xml 39 58 39 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0115-000035">Fleming et al. 1998</xref>
###xml 60 81 60 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51-ehp0115-000035">Theppeang et al. 2004</xref>
###xml 114 131 114 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 133 147 133 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-000035">Wu et al. 2003</xref>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 330 331 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 341 348 341 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-000035">Table 4</xref>
Four studies-two occupational studies (Fleming et al. 1998; Theppeang et al. 2004) and two environmental studies (Smith et al. 1995; Wu et al. 2003)-were analyzed for differences in trabecular lead level and ALAD polymorphism. The overall pooled SMD of -003 (95% CI: 0.16, 0.09) was not significant and heterogeneity was absent (I2 = 0.0%) (Table 4).
###end p 49
###begin title 50
Difference between trabecular and cortical bone lead level
###end title 50
###begin p 51
###xml 27 41 27 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0115-000035">Hu et al. 2001</xref>
###xml 43 60 43 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 94 113 94 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0115-000035">Fleming et al. 1998</xref>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-000035">Table 4</xref>
###xml 454 458 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
Two environmental studies (Hu et al. 2001; Smith et al. 1995) and one involving lead workers (Fleming et al. 1998) were analyzed for differences between trabecular (patella and calcaneus) and cortical (tibia) bone lead levels and ALAD polymorphism. The overall pooled SMD (SMD = 0.03; 95% CI, 0.21 to 0.26) was not significant, but there was moderate heterogeneity (I2 = 50.9%) (Table 4). Overall, these analyses showed no significant difference between ALAD genotypes and trabecular and cortical bone lead concentrations.
###end p 51
###begin title 52
###xml 5 39 5 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphism and DMSA test outcome</italic>
ALAD polymorphism and DMSA test outcome
###end title 52
###begin p 53
###xml 98 119 98 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44-ehp0115-000035">Schwartz et al. 1997b</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0115-000035">2000</xref>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 365 366 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 409 416 408 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-000035">Table 4</xref>
###xml 486 493 485 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
###xml 514 521 513 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2</italic>
Dimercaptosuccinic acid (DMSA) is a chelating agent used to treat lead intoxication. Two studies (Schwartz et al. 1997b, 2000) reported chelatable urinary lead after administration of oral doses of DMSA. The WMD calculated from these studies showed that individuals homozygous for ALAD2 had an average of -21.30 mug of DMSA-chelatable lead (95% CI, 40.81 to -1.79; p = 0.03) higher than heterozygous workers (Table 4). These data indicate that the bioavailability of lead is greater in ALAD1-1 individuals than in ALAD1-2 individuals.
###end p 53
###begin title 54
###xml 5 37 5 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphism and kidney function</italic>
ALAD polymorphism and kidney function
###end title 54
###begin title 55
Serum creatinine
###end title 55
###begin p 56
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 69 90 69 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0115-000035">Bergdahl et al. 1997a</xref>
###xml 92 109 92 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 111 129 111 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57-ehp0115-000035">Weaver et al. 2003</xref>
###xml 131 145 131 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-000035">Wu et al. 2003</xref>
###xml 161 184 161 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0115-000035">Bergdahl et al. (1997a)</xref>
###xml 369 386 369 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 388 402 388 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-000035">Wu et al. 2003</xref>
###xml 438 456 438 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57-ehp0115-000035">Weaver et al. 2003</xref>
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 508 509 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-000035">Table 4</xref>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 871 877 871 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1.</italic>
Four studies reported serum creatinine values and ALAD polymorphism (Bergdahl et al. 1997a; Smith et al. 1995; Weaver et al. 2003; Wu et al. 2003). The study by Bergdahl et al. (1997a) was excluded because it was not possible to calculate the mean and SD. Therefore, only three studies were analyzed by pooled SMD: two conducted in environmentally exposed individuals (Smith et al. 1995; Wu et al. 2003), and one in lead-exposed workers (Weaver et al. 2003). Very high heterogeneity was present (p < 0.001; I2 = 92.9% ) (Table 4), that could be attributed to different levels of lead exposure. Pooled analysis of the two studies reporting low levels of lead exposure (environmental studies) shows that individuals carrying the ALAD2 allele had a corresponding significantly higher serum creatinine (SMD = 0.48; 95% CI, 0.33 to 0.62) than those individuals homozygous for ALAD1.
###end p 56
###begin title 57
###xml 5 36 5 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphism and blood pressure</italic>
ALAD polymorphism and blood pressure
###end title 57
###begin p 58
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 82 100 82 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0115-000035">Lee BK et al. 2001</xref>
###xml 102 119 102 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 278 285 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-000035">Table 4</xref>
Two cross-sectional studies related systolic blood pressure to ALAD polymorphism (Lee BK et al. 2001; Smith et al. 1995). The pooled WMD was 0.30 mmHg higher in individuals carrying the ALAD2 allele, but the difference was not statistically significant (95% CI, -2.18 to 2.78) (Table 4).
###end p 58
###begin p 59
###xml 47 65 47 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0115-000035">Lee BK et al. 2001</xref>
###xml 67 84 67 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 86 100 86 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-000035">Wu et al. 2003</xref>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 161 162 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 162 163 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 172 173 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 182 183 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 183 184 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 195 202 193 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-000035">Table 4</xref>
###xml 278 283 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 399 417 397 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0115-000035">Lee BK et al. 2001</xref>
###xml 449 454 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 563 564 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 564 565 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 574 575 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 664 669 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 700 701 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 711 718 707 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-000035">Table 4</xref>
Heterogeneity was present among three studies (Lee BK et al. 2001; Smith et al. 1995; Wu et al. 2003) relating diastolic blood pressure to ALAD polymorphism (chi22 = 6.16; p = 0.05; I2 = 66.9%) (Table 4). This heterogeneity was most likely due to the different frequency of the ALAD2 allele in the population investigated, as well as the level of lead exposure. Exclusion of the occupational study (Lee BK et al. 2001), which has a low frequency of ALAD2 allele and modestly higher levels of lead exposure, resulted in a nonsignificant test for heterogeneity (chi21 = 0.47, p = 0.49), a significant pooled WMD that was 1.88 mmHg higher in individuals carrying the ALAD2 allele (95% CI, 0.46 to 3.31; p = 0.01) (Table 4).
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
Our goal in this study was to determine the associations of ALAD polymorphism on blood lead levels and bone deposition, and the role of this polymorphism as a modifier of target organ lead toxicity. Overall, our meta-analysis shows that individuals carrying the ALAD2 allele had generally higher blood lead levels than those homozygous for ALAD1. The data suggest that carrying the ALAD allele is a significant determinant for blood lead concentrations among individuals subjected to high levels, such as lead-exposed workers. ALAD2 does not appear to be a significant determinant of blood lead concentrations among adult individuals exposed to relatively low lead levels (<10 mug/dL).
###end p 61
###begin p 62
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 326 347 326 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-ehp0115-000035">Bergdahl et al. 1997b</xref>
###xml 479 484 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 569 574 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 549 555 <span type="species:ncbi:9606">people</span>
The biologic plausibility for a differential role of the two ALAD alleles lies in the fact that the ALAD2 enzyme could potentially have a higher affinity and stability for lead than ALAD1. Among lead workers, carriers of the ALAD2 allele had a higher percentage of lead bound to the ALAD enzyme compared to ALAD1 homozygotes (Bergdahl et al. 1997b). The higher percentage of lead bound to the ALAD 2 enzyme translates to lower levels of bioavailable lead; the reverse is true in ALAD1 homozygotes. This is consistent with our results. We found that people carrying the ALAD2 allele had a weighted average of 21.30 mug lower DMSA-chelatable lead than individuals lacking the allele.
###end p 62
###begin p 63
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 185 195 185 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp0115-000035">Ponka 1997</xref>
The insertion of ferrous iron (Fe2+) into the porphyrin ring to form heme is catalyzed by the mitochondrial enzyme ferrochelatase, which shows reduced activity in the presence of lead (Ponka 1997).This reduction in ferrochelatase activity frees protoporphyrin to accept zinc, resulting in the formation of zinc protophorphyrin, which is characteristically increased in both lead poisoning and iron deficiency.
###end p 63
###begin p 64
###xml 251 253 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
The increased amount of lead bound to the ALAD 2 isozyme should result in decreased lead available to inhibit ferrochelatase, which would thus be available to catalyze the formation of heme with subsequent formation of hemoglobin in the presence of Fe2+. In contrast, the weaker binding of lead to ALAD1 results in more bioavailable lead that can inhibit ferrochelatase. This results in increased formation of ZPP and decreased production of heme and hemoglobin.
###end p 64
###begin p 65
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 452 477 450 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp0115-000035">Baldwin and Marshall 1999</xref>
###xml 541 545 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 718 740 716 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp0115-000035">Schwartz et al. (1995)</xref>
###xml 773 778 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 895 900 893 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 937 960 935 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0115-000035">Alexander et al. (1998)</xref>
###xml 1112 1117 1107 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1</italic>
###xml 1165 1170 1160 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 1201 1218 1195 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp0115-000035">Sakai et al. 2000</xref>
###xml 1262 1266 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 1372 1377 1365 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 442 450 <span type="species:ncbi:9606">children</span>
Our meta-analysis supports these modifying effects of the ALAD2 allele. Hemoglobin level was 0.18 g/dL (95% CI, 0.05 to 0.31) higher in lead workers with the ALAD1-2 genotype. Although ALAD2 carriers had a lower ZPP (SMD = -0.10), the difference was not statistically significant. ZPP is characteristically increased in lead poisoning and starts to rise exponentially only at blood lead concentrations > 30 mug/dL in adults or > 25 mug/dL in children (Baldwin and Marshall 1999). It is thus reasonable to expect a modifying effect on ZPP by ALAD polymorphism with increased lead exposure. The absence of a significant effect could be due to differences in exposure levels to the toxicant across the study populations. Schwartz et al. (1995) found that workers carrying the ALAD2 allele in the plant with the highest lead exposures were associated with lower ZPP measurements. The association of ALAD2 with lower ZPP was also reported by Alexander et al. (1998), and this association was more pronounced in workers with blood lead concentrations >/= 40 mug/dL. Significantly higher levels of ZPP were reported in ALAD1 homozygous Japanese lead workers compared with ALAD2 carriers at BLLs > 20 mug/dL (Sakai et al. 2000). Overall, these studies indicate that the ALAD allele is a modifying factor in the formation of ZPP at higher blood lead levels (> 20 mug/dL), and that ALAD2 carriers exhibit lower levels of ZPP and higher levels of hemoglobin.
###end p 65
###begin p 66
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 352 369 352 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. 1995</xref>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 794 797 794 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 866 886 866 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0115-000035">Schwartz et al. 2000</xref>
###xml 888 909 888 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51-ehp0115-000035">Theppeang et al. 2004</xref>
###xml 1395 1412 1395 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-ehp0115-000035">Dusso et al. 2005</xref>
###xml 1638 1650 1638 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp0115-000035">Fullmer 1990</xref>
###xml 1730 1750 1730 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp0115-000035">Mahaffey et al. 1986</xref>
###xml 1802 1820 1802 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-ehp0115-000035">Bogden et al. 1995</xref>
###xml 1823 1826 1823 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1908 1931 1908 1931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51-ehp0115-000035">Theppeang et al. (2004)</xref>
###xml 2010 2015 2010 2015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR B</italic>
###xml 2024 2046 2024 2046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0115-000035">Schwartz et al. (2000)</xref>
###xml 2119 2124 2119 2124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR B</italic>
###xml 2220 2226 2219 2225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR bb</italic>
###xml 1720 1728 <span type="species:ncbi:9606">children</span>
Differences in lead accumulation in various bone types have been reported. Tibia concentrations differ from those observed in the patella. The cortical bone of the tibia represents a long-term storage depot with an elimination half-life for lead in excess of a decade. ALAD status may modify the way in which lead partitions between these bone depots (Smith et al. 1995). That is, the variant ALAD2 protein may effectively increase the blood and soft tissue (e.g., spleen and kidney) compartment half-lives of lead, thus decreasing partitioning to the cortical bone compartment. Our meta-analysis did not find a significant association between ALAD polymorphism and accumulation of lead in the different bone compartments. More recently, emphasis has focused on the role of vitamin D receptor (VDR) polymorphism in modulating the lead level in the bone compartment (Schwartz et al. 2000; Theppeang et al. 2004). The vitamin D endocrine system plays an essential role in calcium homeostasis and bone metabolism. Vitamin D is a prohormone that is metabolically converted to the active metabolite 1,25-dihydroxyvitamin D (calcitriol), which facilitates calcium absorption from the gut and directly stimulates osteoblasts, the bone-forming cells. These effects are mediated through activation of the VDR, which alters the transcription rates of target genes responsible for the biological response (Dusso et al. 2005). Lead is a divalent cation that behaves like calcium in biological systems, and interactions between lead and calcium have been reported. Calcium and calcitriol deficiencies result in increased lead absorption from the gut (Fullmer 1990). Conversely, higher dietary calcium intake results in lower BLLs in children (Mahaffey et al. 1986) and in reduced bone lead accumulation in animals (Bogden et al. 1995). VDR polymorphism may thus influence lead uptake and retention in bone storage pools. Theppeang et al. (2004) found a significantly higher patella lead burden in lead workers carrying the VDR B allele. Schwartz et al. (2000) previously reported in adjusted analyses that lead workers carrying the VDR B allele had significantly higher tibia lead levels (on average 6.4 mug/g) than workers with the VDR bb genotype.
###end p 66
###begin p 67
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 94 113 94 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-000035">Smith et al. (1995)</xref>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 381 402 381 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0115-000035">Bergdahl et al. 1997a</xref>
###xml 446 453 446 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2</italic>
###xml 505 523 505 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57-ehp0115-000035">Weaver et al. 2003</xref>
###xml 606 611 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 979 984 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 1127 1133 1127 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1.</italic>
Associations of ALAD polymorphism and renal effects of lead exposure have also been reported. Smith et al. (1995) found that the ALAD2 carriers were more susceptible to decrements in renal function as measured by increases in serum creatinine and blood urea nitrogen (BUN). The increased serum creatinine in individuals carrying ALAD2 was confirmed in a sample of 89 lead workers (Bergdahl et al. 1997a). Conversely, Korean lead workers with the ALAD1-2 genotype exhibited lower BUN and serum creatinine (Weaver et al. 2003). The pooled SMD in our meta-analysis showed higher serum creatinine values among ALAD2 carriers. However, there was significant heterogeneity among the studies that might be ascribed to the level of lead exposure, frequency of the polymorphism in the population investigated, and other possible confounders (e.g., age, sex). Pooled analysis of the studies reporting low levels of lead exposure (environmental studies) shows that individuals carrying the ALAD2 allele had a corresponding statistically significant mean average of 0.10 mg/dL higher serum creatinine than those individuals homozygous for ALAD1.
###end p 67
###begin p 68
###xml 72 88 72 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-ehp0115-000035">Kopp et al. 1988</xref>
###xml 90 108 90 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp0115-000035">Pirkle et al. 1985</xref>
###xml 418 419 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 500 501 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 512 530 512 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-ehp0115-000035">Nawrot et al. 2002</xref>
###xml 620 624 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
The effect of lead on blood pressure has also been widely investigated (Kopp et al. 1988; Pirkle et al. 1985). The available literature suggests that there is a positive, albeit weak association between systolic blood pressure and blood lead concentration. A recent meta-analysis showed that a 2-fold increase in blood lead concentration is associated with a rise in systolic pressure of 1.0 mmHg (95% CI, 0.5 to 1.4; p < 0.001) and an increase in diastolic pressure of 0.6 mmHg (95% CI, 0.4 to 0.8; p < 0.001) (Nawrot et al. 2002). Our meta-analysis did not find a difference in systolic blood pressure associated with ALAD polymorphism. However, individuals carrying the ALAD2 allele who were environmentally exposed to lead showed an increase in diastolic blood pressure of 1.88 mmHg.
###end p 68
###begin p 69
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 341 363 341 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp0115-000035">McAllister et al. 1971</xref>
###xml 365 382 365 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39-ehp0115-000035">Roels et al. 1990</xref>
###xml 384 405 384 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41-ehp0115-000035">Sandstead et al. 1970</xref>
###xml 586 587 586 587 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 662 682 662 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55-ehp0115-000035">Vaziri and Ding 2001</xref>
###xml 684 702 684 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54-ehp0115-000035">Vaziri et al. 1999</xref>
###xml 727 731 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 792 794 792 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 830 849 830 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-ehp0115-000035">Colombo et al. 2002</xref>
###xml 851 871 851 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49-ehp0115-000035">Sofowora et al. 2001</xref>
The biological plausibility of a causal relationship between elevated blood pressure and lead exposure has been studied mainly in animals and in vitro. Experiments have demonstrated that lead affects the smooth muscles of blood vessels by interfering with the Na+/K+-pump, cyclic AMP, calcium ions (Ca2+), and the rennin-angiotensin system (McAllister et al. 1971; Roels et al. 1990; Sandstead et al. 1970). In this context, the presence of other polymorphic genes, such as that coding for endothelial nitric oxide synthase (eNOS), may play an additional role. Endothelial NOS converts l-arginine into nitric oxide, causing relaxation of vascular smooth muscle (Vaziri and Ding 2001; Vaziri et al. 1999) and associations among eNOS genotypes, hypertension, lead exposure, and intracellular Ca2+ concentrations have been reported (Colombo et al. 2002; Sofowora et al. 2001).
###end p 69
###begin title 70
Conclusions
###end title 70
###begin p 71
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD2</italic>
###xml 671 692 671 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp0115-000035">Ioannidis et al. 2003</xref>
###xml 929 932 929 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1257 1258 1257 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1380 1381 1380 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
Measurement of blood lead level is the most convenient, readily available, and logistically feasible biomarker for assessing risk of lead toxicity. However, the presence of the ALAD2 allele may obscure the clinical interpretation of blood lead values in terms of target organ toxicity. ALAD2 carriers generally show higher BLLs in adults at increased levels of lead exposure, and appear to be protected against adverse hemapoietic effects as measured by hemoglobin levels. The modifying effects of ALAD on other organs remain unclear, partly because of the the small number of studies. These numbers are relatively small and therefore any inferences have to be cautious (Ioannidis et al. 2003). The strength of the present analysis, however, is based on the aggregation of published studies, thus there is more information for investigating the effect of the allele under investigation. Moreover, the role of other genes such as VDR could alter lead deposition in bone. The increasing application of molecular epidemiologic methods has emphasized the interaction between genes and the environment. Multiple gene polymorphisms suggest that genes having a small effect may interact to determine the overall risk. This meta-analysis identifies several issues: a) there are numerous potential sources of heterogeneity, including varying allele frequencies and HWE in the populations; b) in the context of gene-environment interactions, gene-gene interactions may play a role (for example, ALAD, VDR, and eNOS may interact to modify lead levels in several organs).
###end p 71
###begin title 72
Figures and Tables
###end title 72
###begin p 73
Flow chart of study selection.
###end p 73
###begin p 74
###xml 57 68 57 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2/2-2</italic>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
Random-effect WMD and 95% CI in blood lead level between ALAD1-2/2-2 and ALAD1-1 carriers.
###end p 74
###begin p 75
###xml 40 51 40 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2/2-2</italic>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
Random-effect SMD in ZPP values between ALAD1-2/2-2 and ALAD1-1 carriers.
###end p 75
###begin p 76
###xml 47 58 47 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2/2-2</italic>
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
Random-effect WMD in hemoglobin values between ALAD1-2/2-2 and ALAD1-1 carriers.
###end p 76
###begin p 77
Characteristics of the studies included in the review.
###end p 77
###begin p 78
Abbreviations: BLL, blood lead level; BUN, blood urea nitrogen; CBL, calcaneus bone lead; DBP, diastolic blood pressure; DMSA, DMSA-chelatable lead; HB, hemoglobin; PBL, patella bone lead; SBP, systolic blood pressure; SC, serum creatinine; TBL, tibia bone lead; ZPP, zinc protoporphyrin.
###end p 78
###begin p 79
These studies use the same population data.
###end p 79
###begin p 80
These studies use the same population data.
###end p 80
###begin p 81
These studies use the same population data.
###end p 81
###begin p 82
These studies use the same population data.
###end p 82
###begin p 83
These studies use the same population data.
###end p 83
###begin p 84
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD</italic>
Frequency of ALAD allele and HWE in the studies analyzed.
###end p 84
###begin p 85
###xml 43 54 43 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2/2-2</italic>
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
Summary effect size of blood lead level in ALAD1-2/2-2 versus ALAD1-1 carriers.
###end p 85
###begin p 86
NA, not applicable.
###end p 86
###begin p 87
###xml 27 28 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistically significant, p < 0.05.
###end p 87
###begin p 88
###xml 28 39 28 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-2/2-2</italic>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAD1-1</italic>
Summary effect size between ALAD1-2/2-2 and ALAD1-1 carriers on various outcomes.
###end p 88
###begin p 89
WMD.
###end p 89
###begin title 90
References
###end title 90
###begin article-title 91
Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers
###end article-title 91
###begin article-title 92
delta-Aminolevulinic acid dehydratase isozymes and lead toxicity
###end article-title 92
###begin article-title 93
Heavy metal poisoning and its laboratory investigation
###end article-title 93
###begin article-title 94
###xml 63 66 <span type="species:ncbi:9606">man</span>
delta-Aminolevulinate dehydrase: a new genetic polymorphism in man
###end article-title 94
###begin article-title 95
Operating characteristics of a rank correlation test for publication bias
###end article-title 95
###begin article-title 96
Attentional correlates of dentin and bone lead levels in adolescent
###end article-title 96
###begin article-title 97
###xml 100 106 <span type="species:ncbi:9606">humans</span>
delta-Aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans
###end article-title 97
###begin article-title 98
###xml 64 69 <span type="species:ncbi:9606">human</span>
Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes
###end article-title 98
###begin article-title 99
###xml 118 122 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Dietary calcium and lead interact to modify maternal blood pressure, erythropoiesis, and fetal and neonatal growth in rats during pregnancy and lactation
###end article-title 99
###begin article-title 100
Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors
###end article-title 100
###begin article-title 101
###xml 82 90 <span type="species:ncbi:9606">children</span>
Erythrocyte porphobilinogen synthase activity as an indicator of lead exposure in children
###end article-title 101
###begin article-title 102
Evidence for association of a common variant of the endothelialnitric oxide synthase gene (Glu298-Asp polymorphism) to the presence, extent, and severity of coronary artery disease
###end article-title 102
###begin article-title 103
Vitamin D
###end article-title 103
###begin article-title 104
Influence of delta-aminolevulinic acid dehydratase (ALAD) polymorphism on the frequency of sister chromatid exchange (SCE) and the number of high-frequency cells (HFCs) in lymphocytes from lead-exposed workers
###end article-title 104
###begin article-title 105
Bias in meta-analysis detected by a simple graphic test
###end article-title 105
###begin article-title 106
Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers
###end article-title 106
###begin article-title 107
Intestinal lead and calcium absorption: effect of 1,25-dihydroxycholecalciferol and lead status
###end article-title 107
###begin article-title 108
Measuring inconsistency in meta-analyses
###end article-title 108
###begin article-title 109
Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan
###end article-title 109
###begin article-title 110
###xml 114 117 <span type="species:ncbi:9606">men</span>
The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study
###end article-title 110
###begin article-title 111
Genetic associations in large versus small studies: an empirical assessment
###end article-title 111
###begin article-title 112
delta-Aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review
###end article-title 112
###begin article-title 113
The protective effect of delta-aminolevulinic acid dehydratase 1-2 and 2-2 isozymes against blood lead with higher hematologic parameters
###end article-title 113
###begin article-title 114
Cardiovascular actions of lead and relationship to hypertension: a review
###end article-title 114
###begin article-title 115
Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes
###end article-title 115
###begin article-title 116
Associations of lead biomarkers and delta-aminolevulinic acid dehydratase and vitamin D receptor genotypes with hematopoietic outcomes in Korean lead workers
###end article-title 116
###begin article-title 117
###xml 66 74 <span type="species:ncbi:9606">children</span>
Blood lead levels and dietary calcium intake in 1- to 11-year-old children: the Second National Health and Nutrition Examination Survey, 1976-1980
###end article-title 117
###begin article-title 118
###xml 91 97 <span type="species:ncbi:9606">humans</span>
Multicompartment kinetic models for lead: Part I. Bone kinetics and variable absorption in humans without excessive lead exposures
###end article-title 118
###begin article-title 119
###xml 94 100 <span type="species:ncbi:9606">humans</span>
Multicompartment kinetic models for lead: Part II. Linear kinetics and variable absorption in humans without excessive lead exposures
###end article-title 119
###begin article-title 120
Plasma renin activity in chronic plumbism
###end article-title 120
###begin article-title 121
An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis
###end article-title 121
###begin article-title 122
Genetic susceptibility to lead poisoning
###end article-title 122
###begin article-title 123
###xml 81 89 <span type="species:ncbi:9606">children</span>
Association between aminolevulinate dehydrase genotypes and blood lead levels in children from a lead-contaminated area in Antofagasta, Chile
###end article-title 123
###begin article-title 124
The relationship between blood lead levels and blood pressure and its cardiovascular risk implications
###end article-title 124
###begin article-title 125
Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells
###end article-title 125
###begin article-title 126
###xml 48 54 <span type="species:ncbi:9606">humans</span>
Kinetics analysis of lead metabolism in healthy humans
###end article-title 126
###begin article-title 127
Urinary kallikrein activity in workers exposed to cadmium, lead, or mercury vapour
###end article-title 127
###begin article-title 128
Relationship between delta-aminolevulinic acid dehydratase genotypes and heme precursors in lead workers
###end article-title 128
###begin article-title 129
Lead intoxication. Its effect on the renin-aldosterone response to sodium deprivation
###end article-title 129
###begin article-title 130
Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers
###end article-title 130
###begin article-title 131
Associations of subtypes of hemoglobin with delta-aminolevulinic acid dehydratase genotype and dimercaptosuccinic acid-chelatable lead levels
###end article-title 131
###begin article-title 132
delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid
###end article-title 132
###begin article-title 133
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes
###end article-title 133
###begin article-title 134
###xml 80 88 <span type="species:ncbi:9606">children</span>
delta-Aminolevulinate dehydratase polymorphism and blood lead levels in Chinese children
###end article-title 134
###begin article-title 135
Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers
###end article-title 135
###begin article-title 136
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead
###end article-title 136
###begin article-title 137
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo effect of Glu298Asp endothelial nitric oxide synthase polymorphism
###end article-title 137
###begin article-title 138
Influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism on biomarkers of lead exposure in Turkish storage battery manufacturing workers
###end article-title 138
###begin article-title 139
Associations of patella lead with polymorphisms in the vitamin D receptor, delta-aminolevulinic acid dehydratase and endothelial nitric oxide synthase genes
###end article-title 139
###begin article-title 140
Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations
###end article-title 140
###begin article-title 141
Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension
###end article-title 141
###begin article-title 142
Effect of lead on nitric oxide synthase expression in coronary endothelial cells
###end article-title 142
###begin article-title 143
Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase
###end article-title 143
###begin article-title 144
Associations of renal function with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers
###end article-title 144
###begin article-title 145
###xml 121 129 <span type="species:ncbi:9606">children</span>
The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes
###end article-title 145
###begin article-title 146
###xml 31 36 <span type="species:ncbi:9606">human</span>
Molecular characterization the human delta-aminolevulinate dehydratase 2 (ALAD 2 ) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning
###end article-title 146
###begin article-title 147
Lack of association of delta-aminolevulinic acid dehydratase genotype with cytogenetic damage in lead workers
###end article-title 147
###begin article-title 148
A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study
###end article-title 148
###begin article-title 149
Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers
###end article-title 149
###begin p 150
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the ATSDR.
###end p 150
###begin p 151
This project was supported under a cooperative agreement form the CDC through the Association of Teachers of Preventive Medicine. Franco Scinicariello is a recipient of an ATPM (Association of Teachers of Preventive Medicine) Career Development Award.
###end p 151

